Consun Pharmaceutical Announces Board and Management Reshuffle

Story Highlights
Consun Pharmaceutical Announces Board and Management Reshuffle

An update from Consun Pharmaceutical Group Ltd. ( (HK:1681) ) is now available.

Consun Pharmaceutical Group Ltd. announced significant changes in its board composition and management, effective from February 24, 2025. Ms. Chen Yujun has resigned as an independent non-executive Director to take on the role of Chief Financial Officer, while Mr. Li Zhuoguang is appointed as an independent non-executive Director and the chairman of the Audit Committee. These changes reflect a strategic reallocation of responsibilities aimed at strengthening the company’s governance and financial oversight.

More about Consun Pharmaceutical Group Ltd.

Consun Pharmaceutical Group Limited is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry. It operates together with its subsidiaries, supplying pharmaceutical products and services.

YTD Price Performance: -15.05%

Average Trading Volume: 3,386

Technical Sentiment Consensus Rating: Sell

Current Market Cap: €830.4M

See more insights into 1681 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App